Molecular mechanisms of resistance to taxanes and therapeutic implications
- 1 December 1999
- journal article
- Published by Elsevier in Drug Resistance Updates
- Vol. 2 (6) , 351-357
- https://doi.org/10.1054/drup.1999.0108
Abstract
No abstract availableKeywords
This publication has 52 references indexed in Scilit:
- Mechanisms of Action of and Resistance to Antitubulin Agents: Microtubule Dynamics, Drug Transport, and Cell DeathJournal of Clinical Oncology, 1999
- Malignant glioma: Should chemotherapy be overthrown by experimental treatments?Annals of Oncology, 1998
- Advances in brain tumor chemosensitivityCurrent Opinion in Oncology, 1998
- Comparative antitumor efficacy of docetaxel and paclitaxel in nude mice bearing human tumor xenografts that overexpress the multidrug resistance protein (MRP)Annals of Oncology, 1997
- Limited oral bioavailability and active epithelial excretion of paclitaxel (Taxol) caused by P-glycoprotein in the intestineProceedings of the National Academy of Sciences, 1997
- Taxol Differentially Modulates the Dynamics of Microtubules Assembled from Unfractionated and Purified β-Tubulin IsotypesBiochemistry, 1997
- Co-expression of several molecular mechanisms of multidrug resistance and their significance for paclitaxel cytotoxicity in human AML HL-60 cellsLeukemia, 1997
- MRP gene overexpression in a human doxorubicin‐resistant SCLC cell line: Alterations in cellular pharmacokinetics and in pattern of cross‐resistanceInternational Journal of Cancer, 1995
- Characterization of a Taxol‐resistant Human Small‐cell Lung Cancer Cell LineJapanese Journal of Cancer Research, 1994
- Multidrug ResistanceAnnual Review of Medicine, 1991